Remove 2021 Remove Diabetes Remove Immunization
article thumbnail

Transitions of Care Pharmacists Mitigate Readmission Rates for COPD

Pharmacy Times

The retrospective cohort study included all patients who met the criteria for the Medicare HRRP COPD model discharged between May 2021 and August 2023. The researchers included 187 patients and 92 patients in the pre- and postimplementation groups, respectively.

article thumbnail

Secondary Analysis Investigates Spillover Effects of Antibiotic Audit and Feedback

Pharmacy Times

The trial was conducted from January 2021 to December 2022, with a feedback letter sent on or after January 2022, including physicians that were randomly assigned in a 4 to 1 allocation. The misuse and overuse of antimicrobials to treat, prevent, and control infections has influenced the spread of AMR.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA Approves Vancomycin Injection For Ready-to-Infuse Sepsis Therapy

Pharmacy Times

Updated May 17, 2021. Hikma receives FDA approval for TYZAVANTM (Vancomycin Injection, USP) in the US. News release. July 2, 2025. Accessed July 2, 2025. Cleveland Clinic. Septicemia. News release. Accessed July 2, 2025. Cleveland Clinic. Endocarditis. News release. Updated May 12, 2025. Accessed July 2, 2025.

article thumbnail

ADA 2025: Oral Semaglutide Demonstrates Cardiovascular Benefits in SOUL Trial

Pharmacy Times

Experts emphasized oral semaglutide as a promising alternative to injectable GLP-1 receptor agonists for managing diabetes and cardiovascular risk. SHOW MORE Oral semaglutide shows promising cardiovascular benefits for type 2 diabetes patients, reducing major adverse events by 14% in the SOUL trial.

article thumbnail

Does Corticosteroid Use Have a Role in Severe Community-Acquired Pneumonia?

Pharmacy Times

Community-acquired pneumonia (CAP) is a common infection caused by the inhalation of various organisms into the lower respiratory tract, which can ultimately initiate an immune and inflammatory response, potentially leading to damage to lung parenchyma. Am J Respir Crit Care Med. 2019;200(7):e45-e67. doi:10.1164/rccm.201908-1581ST

article thumbnail

ADA: Vertex closer to weaning type 1 diabetics off insulin

pharmaphorum

Skip to main content Tuesday 24 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

Drawn to Understand: How Culturally Tailored Education Empowers Patients With Type 1 Diabetes

Pharmacy Times

Culturally tailored educational materials are more than just translated pamphlets—they are bridges between knowledge and understanding, especially for individuals navigating a new type 1 diabetes (T1D) diagnosis in underserved or cross-cultural settings. Improved glycemic control and diabetes knowledge within 6 months. The result?